Table 2.
Data sets used for model development.
| Population | Intervention | Source |
|---|---|---|
| healthy male athletes | 200 IU/kg EPO sc (d 0, 2, 4, 7, 10) without iron medication | 8 |
| healthy male subjects | 300 IU/kg EPO sc (d 0, 3, 6, 9) 300 mg oral iron (d 0–9) | 9 |
| healthy male subjects | 400 IU/kg EPO sc (d 0, 4, 8) 300 mg oral iron (d 0–9) | 9 |
| healthy male subjects | 600 IU/kg EPO sc (d 0, 9) 300 mg oral iron (d 0–9) | 9 |
| blood donors | donation of 500 ml blood without iron medication | 10 |
| blood donors | donation of 500 ml blood with oral ferrous gluconate, 325 mg daily | 10 |
| lymphoma patients | CHOP chemotherapy | 11,15 |
| healthy subjects | 100 IU EPO iv | 46 |